PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹265 Cr | ₹271 Cr | ₹85 Cr | ₹960 Cr | ₹741 Cr |
What is the latest Total Non-Current Liabilities ratio of PANACEA BIOTEC ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹265 Cr |
Mar2023 | ₹271 Cr |
Mar2022 | ₹85 Cr |
Mar2021 | ₹960 Cr |
Mar2020 | ₹741 Cr |
How is Total Non-Current Liabilities of PANACEA BIOTEC Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹265 Cr | -2.07 | |
Mar2023 | ₹271 Cr | 218.11 | |
Mar2022 | ₹85 Cr | -91.14 | |
Mar2021 | ₹960 Cr | 29.61 | |
Mar2020 | ₹741 Cr | - |
Compare Total Non-Current Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹2,605.6 Cr | -1.7% | -0.3% | 193.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | -1.7% |
-0.3% |
193.2% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses